Archive: 2025/11 - Page 2

By Barrie av / Nov, 18 2025

How Azilsartan Medoxomil Improves Blood Pressure Control in Patients with Psychiatric Disorders

Azilsartan medoxomil offers effective, well-tolerated blood pressure control for patients with psychiatric disorders, reducing hypertension without worsening mental health symptoms or causing weight gain.

By Barrie av / Nov, 18 2025

Pediatric Antihistamine Dosing Errors: How to Prevent Dangerous Side Effects

Pediatric antihistamine dosing errors cause thousands of emergency visits each year. Learn how to avoid dangerous mistakes with Benadryl, Zyrtec, and Claritin by using weight-based dosing, proper measuring tools, and safer second-generation options.

By Barrie av / Nov, 18 2025

Nutrition Guidelines for Patients with Congestive Heart Failure

Learn the essential nutrition guidelines for managing congestive heart failure, including low-sodium diets, fluid limits, safe foods to eat, and what to avoid. Practical tips to improve symptoms and reduce hospital visits.

By Barrie av / Nov, 17 2025

Long-term safety of generics vs. brand-name drugs: what the data really shows

Long-term safety studies show generics are generally as safe as brand-name drugs, but for critical medications, manufacturer, formulation, and individual response matter. Here’s what the data reveals about real-world outcomes.

By Barrie av / Nov, 17 2025

Antiseizure Medications and Generic Substitution: Risks and Best Practices

Generic antiseizure medications save money but can trigger breakthrough seizures in some patients due to narrow therapeutic index. Learn the risks, who's most vulnerable, and how to protect yourself.

By Barrie av / Nov, 17 2025

Ezetimibe Side Effects: Understanding GI Symptoms and Tolerability

Ezetimibe is a well-tolerated cholesterol-lowering drug with mild, temporary GI side effects like diarrhea and gas. Learn how common they are, how to manage them, and why it’s often better than statins for sensitive stomachs.

By Barrie av / Nov, 16 2025

ANDA Process: Legal Requirements for Generic Drug Approval in the U.S.

The ANDA process is the legal pathway for generic drug approval in the U.S., requiring bioequivalence, identical formulation, and strict manufacturing standards under the Hatch-Waxman Act. It saves billions and enables 90% of prescriptions to be filled with generics.